PL2202307T3 - Sposób wytwarzania przeciwciała - Google Patents

Sposób wytwarzania przeciwciała

Info

Publication number: PL2202307T3
Authority: PL; Poland
Prior art keywords: antibody; production
Prior art date: 2007-10-15

Application number

PL08838661T

Other languages

English (en)

Other versions

PL2202307T5 (pl

Inventor

Yoshiki Yamada

Tatsuya Kiyasu

Kazuyuki Tabata

Akihiro Kuzumaki

Mai Yamashiro

Original Assignee

Chugai Pharmaceutical Co Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-10-15

Filing date

2008-10-14

Publication date

2015-02-27

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40567372&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2202307(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2008-10-14 Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd

2015-02-27 Publication of PL2202307T3 publication Critical patent/PL2202307T3/pl

2021-10-04 Publication of PL2202307T5 publication Critical patent/PL2202307T5/pl

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2510/00—Genetically modified cells
- C12N2510/02—Cells for production

Landscapes

Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Immunology (AREA)
Molecular Biology (AREA)
Genetics & Genomics (AREA)
Biophysics (AREA)
Biochemistry (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Peptides Or Proteins (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicinal Preparation (AREA)

PL08838661T 2007-10-15 2008-10-14 Sposób wytwarzania przeciwciała PL2202307T5 (pl)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
JP2007267384		2007-10-15
JP2008103308		2008-04-11
EP08838661.0A EP2202307B2 (en)	2007-10-15	2008-10-14	Method for production of antibody
PCT/JP2008/068588 WO2009051108A1 (ja)	2007-10-15	2008-10-14	抗体の製造方法

Publications (2)

Publication Number	Publication Date
PL2202307T3 true PL2202307T3 (pl)	2015-02-27
PL2202307T5 PL2202307T5 (pl)	2021-10-04

Family

ID=40567372

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL08838661T PL2202307T5 (pl)	2007-10-15	2008-10-14	Sposób wytwarzania przeciwciała

Country Status (17)

Country	Link
US (2)	US9683027B2 (pl)
EP (1)	EP2202307B2 (pl)
JP (4)	JP4976502B2 (pl)
KR (1)	KR101558009B1 (pl)
CN (3)	CN103540632A (pl)
AU (1)	AU2008312937B2 (pl)
BR (1)	BRPI0818674B1 (pl)
CA (1)	CA2701338C (pl)
DK (1)	DK2202307T4 (pl)
ES (1)	ES2499391T5 (pl)
IL (2)	IL205051A (pl)
MX (1)	MX2010004007A (pl)
PL (1)	PL2202307T5 (pl)
SG (1)	SG185302A1 (pl)
SI (1)	SI2202307T2 (pl)
TW (1)	TWI463010B (pl)
WO (1)	WO2009051108A1 (pl)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP2202307B2 (en) *	2007-10-15	2021-07-14	Chugai Seiyaku Kabushiki Kaisha	Method for production of antibody
SI2493922T1 (sl)	2009-10-26	2017-06-30	F. Hoffmann-La Roche Ag	Postopek za proizvodnjo glikoziliranega imunoglobulina
MX345399B (es) *	2010-12-28	2017-01-30	Chugai Pharmaceutical Co Ltd	Metodo de cultivo de celulas animales.
KR102202476B1 (ko) *	2013-03-15	2021-01-12	제넨테크, 인크.	세포 배양 배지 및 항체 생산 방법
MX363403B (es)	2013-07-04	2019-03-22	Hoffmann La Roche	Inmumoensayo con interferencia suprimida para la deteccion de anticuerpos anti-farmacos en muestras de suero.
WO2018002036A1 (en)	2016-06-28	2018-01-04	Zaklady Farmaceutyczne Polpharma Sa	Recombinant production of monoclonal antibodies
WO2018091729A2 (en)	2016-11-21	2018-05-24	Zaklady Farmaceutyczne Polpharma Sa	Aqueous pharmaceutical formulations

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB8607679D0 (en)	1986-03-27	1986-04-30	Winter G P	Recombinant dna product
JPS6459878A (en)	1987-08-31	1989-03-07	Matsushita Electric Ind Co Ltd	Semiconductor laser protective circuit
GB9015198D0 (en)	1990-07-10	1990-08-29	Brien Caroline J O	Binding substance
ES2139598T3 (es)	1990-07-10	2000-02-16	Medical Res Council	Procedimientos para la produccion de miembros de parejas de union especifica.
DK0814159T3 (da)	1990-08-29	2005-10-24	Genpharm Int	Transgene, ikke-humane dyr, der er i stand til at danne heterologe antistoffer
WO1994025585A1 (en)	1993-04-26	1994-11-10	Genpharm International, Inc.	Transgenic non-human animals capable of producing heterologous antibodies
JPH06500470A (ja) †	1990-09-04	1994-01-20	メルク　エンド　カンパニー　インコーポレーテッド	メチロトローフ酵母細胞におけるインスリン様成長因子の産生
KR100249937B1 (ko)	1991-04-25	2000-04-01	나가야마 오사무	인간 인터루킨-6 수용체에 대한 재구성 인간 항체
EP0605522B1 (en)	1991-09-23	1999-06-23	Medical Research Council	Methods for the production of humanized antibodies
WO1993011236A1 (en)	1991-12-02	1993-06-10	Medical Research Council	Production of anti-self antibodies from antibody segment repertoires and displayed on phage
JPH07503132A (ja)	1991-12-17	1995-04-06	ジェンファーム　インターナショナル，インコーポレイティド	異種抗体を産生することができるトランスジェニック非ヒト動物
CA2131151A1 (en)	1992-03-24	1994-09-30	Kevin S. Johnson	Methods for producing members of specific binding pairs
CA2140638C (en)	1992-07-24	2010-05-04	Raju Kucherlapati	Generation of xenogeneic antibodies
GB9313509D0 (en)	1993-06-30	1993-08-11	Medical Res Council	Chemisynthetic libraries
CA2177367A1 (en)	1993-12-03	1995-06-08	Andrew David Griffiths	Recombinant binding proteins and peptides
KR100261941B1 (ko)	1994-07-13	2000-07-15	나가야마 오사무	사람의 인터루킨-8에 대한 재구성 사람항체
US5561053A (en)	1994-08-05	1996-10-01	Genentech, Inc.	Method for selecting high-expressing host cells
ES2304786T3 (es)	1995-04-27	2008-10-16	Amgen Fremont Inc.	Anticuerpos anti-il-8 humanos, derivados a partir de xenoratones inmunizados.
EP0823941A4 (en)	1995-04-28	2001-09-19	Abgenix Inc	HUMAN ANTIBODIES DERIVED FROM IMMUNIZED XENO MOUSES
WO1998047343A2 (en) *	1997-04-04	1998-10-29	Biosite Diagnostics, Inc.	Antibodies or binding protein libraries displayed on phage, cells, or other replicatable genetic packages
US20020062010A1 (en)	1997-05-02	2002-05-23	Genentech, Inc.	Method for making multispecific antibodies having heteromultimeric and common components
WO1998050431A2 (en)	1997-05-02	1998-11-12	Genentech, Inc.	A method for making multispecific antibodies having heteromultimeric and common components
US6171586B1 (en) *	1997-06-13	2001-01-09	Genentech, Inc.	Antibody formulation
EP1383800A4 (en) †	2001-04-02	2004-09-22	Idec Pharma Corp	RECOMBINANT ANTIBODIES CO-EXPRESSED WITH GNTIII
US6605176B2 (en) *	2001-07-13	2003-08-12	Taiwan Semiconductor Manufacturing Co., Ltd.	Aperture for linear control of vacuum chamber pressure
US20030157641A1 (en)	2001-11-16	2003-08-21	Idec Pharmaceuticals Corporation	Polycistronic expression of antibodies
AU2002364956C1 (en) *	2001-11-16	2009-05-28	Biogen Idec Inc.	Polycistronic expression of antibodies
EP2204190A1 (en)	2003-07-15	2010-07-07	Chugai Seiyaku Kabushiki Kaisha	IgM production by transformed cells and methods for quantifying said IgM production
JP2007529223A (ja) *	2004-03-15	2007-10-25	バイオジェン・アイデック・エムエイ・インコーポレイテッド	選択的スプライシングを用いて真核細胞においてポリペプチドマルチマーを発現するための方法および構築物
CN105820249A (zh)	2004-07-09	2016-08-03	中外制药株式会社	抗-磷脂酰肌醇蛋白聚糖3 抗体
GB0425534D0 (en)	2004-11-19	2004-12-22	Celltech R&D Ltd	Process for obtaining antibodies
TW200745332A (en) †	2005-07-21	2007-12-16	Abbott Lab	Multiple gene expression including sorf constructs and methods with polyproteins, pro-proteins, and proteolysis
EP2202307B2 (en) *	2007-10-15	2021-07-14	Chugai Seiyaku Kabushiki Kaisha	Method for production of antibody

2008
- 2008-10-14 EP EP08838661.0A patent/EP2202307B2/en active Active
- 2008-10-14 PL PL08838661T patent/PL2202307T5/pl unknown
- 2008-10-14 JP JP2009538093A patent/JP4976502B2/ja active Active
- 2008-10-14 BR BRPI0818674-0A patent/BRPI0818674B1/pt active IP Right Grant
- 2008-10-14 AU AU2008312937A patent/AU2008312937B2/en active Active
- 2008-10-14 MX MX2010004007A patent/MX2010004007A/es active IP Right Grant
- 2008-10-14 WO PCT/JP2008/068588 patent/WO2009051108A1/ja active Application Filing
- 2008-10-14 SI SI200831306T patent/SI2202307T2/sl unknown
- 2008-10-14 KR KR1020107008087A patent/KR101558009B1/ko active IP Right Grant
- 2008-10-14 CN CN201310401442.2A patent/CN103540632A/zh active Pending
- 2008-10-14 ES ES08838661T patent/ES2499391T5/es active Active
- 2008-10-14 CN CN200880106430A patent/CN101802192A/zh active Pending
- 2008-10-14 DK DK08838661.0T patent/DK2202307T4/da active
- 2008-10-14 US US12/734,094 patent/US9683027B2/en active Active
- 2008-10-14 CA CA2701338A patent/CA2701338C/en active Active
- 2008-10-14 CN CN201610656433.1A patent/CN106244651A/zh active Pending
- 2008-10-14 SG SG2012076485A patent/SG185302A1/en unknown
- 2008-10-15 TW TW097139552A patent/TWI463010B/zh active
2010
- 2010-04-13 IL IL205051A patent/IL205051A/en active IP Right Grant
2012
- 2012-04-12 JP JP2012090908A patent/JP5788830B2/ja active Active
2015
- 2015-06-05 JP JP2015114464A patent/JP6092304B2/ja active Active
- 2015-07-23 IL IL240122A patent/IL240122B/en active IP Right Grant
2017
- 2017-02-08 JP JP2017020965A patent/JP6506786B2/ja active Active
- 2017-05-08 US US15/589,000 patent/US11136375B2/en active Active

Also Published As

Publication number	Publication date
JP4976502B2 (ja)	2012-07-18
BRPI0818674B1 (pt)	2023-01-17
JPWO2009051108A1 (ja)	2011-03-03
BRPI0818674A2 (pt)	2014-10-14
US20170275351A1 (en)	2017-09-28
MX2010004007A (es)	2010-06-15
PL2202307T5 (pl)	2021-10-04
CA2701338A1 (en)	2009-04-23
JP2012143246A (ja)	2012-08-02
SI2202307T2 (sl)	2021-11-30
EP2202307A1 (en)	2010-06-30
IL240122A0 (en)	2015-09-24
JP6092304B2 (ja)	2017-03-08
US11136375B2 (en)	2021-10-05
AU2008312937A1 (en)	2009-04-23
IL240122B (en)	2019-02-28
JP5788830B2 (ja)	2015-10-07
DK2202307T4 (da)	2021-10-04
CN101802192A (zh)	2010-08-11
AU2008312937B2 (en)	2015-01-22
US9683027B2 (en)	2017-06-20
ES2499391T3 (es)	2014-09-29
KR101558009B1 (ko)	2015-10-19
US20100291627A1 (en)	2010-11-18
JP2017079794A (ja)	2017-05-18
EP2202307B2 (en)	2021-07-14
JP2015198663A (ja)	2015-11-12
DK2202307T3 (da)	2014-09-15
CN106244651A (zh)	2016-12-21
CN103540632A (zh)	2014-01-29
CA2701338C (en)	2018-09-18
IL205051A (en)	2015-09-24
US20210300996A1 (en)	2021-09-30
IL205051A0 (en)	2010-11-30
TWI463010B (zh)	2014-12-01
JP6506786B2 (ja)	2019-04-24
WO2009051108A1 (ja)	2009-04-23
ES2499391T5 (es)	2021-12-22
TW200934867A (en)	2009-08-16
EP2202307B1 (en)	2014-08-20
SG185302A1 (en)	2012-11-29
SI2202307T1 (sl)	2014-11-28
KR20100074184A (ko)	2010-07-01
EP2202307A4 (en)	2012-01-25

Publication	Publication Date	Title
HK1219741A1 (zh)	2017-04-13	結構域抗體的生產方法
PL1903019T3 (pl)	2016-01-29	Sposób wytwarzania izoolefin
IL201082A0 (en)	2010-05-17	Bispecific antibodies and methods for production thereof
EP2326707A4 (en)	2012-05-16	PROCESS FOR PRODUCING ISOPRENOIDS
EP2157074A4 (en)	2011-09-14	PROCESS FOR THE PRODUCTION OF ACROLEINE
EP2223911A4 (en)	2011-10-26	PROCESS FOR THE PRODUCTION OF LAUROLACTAM
EP2135946A4 (en)	2010-10-13	METHOD FOR MANUFACTURING A POLYPEPTIDE
EP2169075A4 (en)	2012-09-19	PREPARATION FOR ALKALOID
IL197823A0 (en)	2009-12-24	Methods for improving antibody production
IL240122B (en)	2019-02-28	A method for producing an antibody
EP2123635A4 (en)	2010-11-10	PROCESS FOR THE PRODUCTION OF LAUROLACTAM
EP2192191A4 (en)	2010-09-01	PRODUCTION PROCESS FOR CAROTENOID
EP2233548A4 (en)	2014-04-09	PROCESS FOR PRODUCING FERROCOKE
EP2088136A4 (en)	2012-10-10	PROCESS FOR PRODUCING HYDROXYADAMANTANE-AMINE
EP2266943A4 (en)	2014-03-12	PROCESS FOR PRODUCING 2-ALKYL-2-CYCLOALCENE-1-ONE
EP2183296A4 (en)	2014-08-27	PROCESS FOR PRODUCTION OF BIOCARBURANT
EP2221384A4 (en)	2011-04-06	METHOD FOR MANUFACTURING ANTIBODY
EP2221294A4 (en)	2012-03-07	PROCESS FOR PREPARING N-CARBAMOYL-TERT.-LEUCIN
PL385356A1 (pl)	2009-12-07	Sposób wytwarzania tadalafilu
EP1985611A4 (en)	2011-02-23	PROCESS FOR THE PREPARATION OF O-METHYL-N-NITROISOHARNSTOFF
EP2119772A4 (en)	2010-11-17	PROCESS FOR MANUFACTURING TRACP5b
EP1997812A4 (en)	2010-05-12	PROCESS FOR THE PREPARATION OF A CHINAZOLIN-4-ON DERIVATIVE
IL200230A0 (en)	2010-04-29	Method for the production of ??-ketonitriles
PL382168A1 (pl)	2007-10-01	Sposób wytwarzania S-(-)- 8-metoksy -2 tetralolu
HK1134925A1 (en)	2010-05-20	Method for the production of benzofuran-2-carboxamides